Drugs that contain Sodium Phenylbutyrate; Taurursodiol

1. Drug name - RELYVRIO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10857162 AMYLYX Compositions for improving cell viability and methods of use thereof
Dec, 2033

(11 years from now)

US10251896 AMYLYX Compositions for improving cell viability and methods of use thereof
Dec, 2033

(11 years from now)

US9872865 AMYLYX Compositions for improving cell viability and methods of use thereof
Dec, 2033

(11 years from now)

US11071742 AMYLYX Compositions for improving cell viability and methods of use thereof
Dec, 2033

(11 years from now)

Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Sep 29, 2027

Market Authorisation Date: 29 September, 2022

Treatment: Treatment of amyotrophic lateral sclerosis (als) in adults

Dosage: FOR SUSPENSION;ORAL

More Information on Dosage
Strength Dosage Availability
3GM/PACKET; 1GM/PACKET FOR SUSPENSION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.